Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation
Citation
Hislop , J , Quayyum , Z , Elders , A , Fraser , C , Jenkinson , D , Mowatt , G , Sharma , P , Vale , L & Petty , R 2011 , ' Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day : a systematic review and economic evaluation ' , Health Technology Assessment , vol. 15 , no. 25 , pp. 1-178 . https://doi.org/10.3310/hta15250